Dongfeng Gu Selected Research

Atherosclerotic Plaque (Atheroma)

2/2022

MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongfeng Gu Research Topics

Disease

53	Hypertension (High Blood Pressure) 01/2023 - 12/2002
35	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 11/2004
15	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2005
12	Essential Hypertension 06/2011 - 02/2003
10	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 06/2004
9	Stroke (Strokes) 05/2024 - 11/2007
9	Atherosclerosis 01/2023 - 01/2005
8	Myocardial Infarction 01/2018 - 01/2004
7	Obesity 10/2021 - 11/2004
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2018 - 04/2004
5	Diabetes Mellitus 05/2024 - 11/2007
5	Type 2 Diabetes Mellitus (MODY) 11/2023 - 11/2004
5	Genetic Risk Score 11/2023 - 02/2016
5	Abdominal Obesity 01/2018 - 04/2007
3	Hemorrhagic Stroke 05/2024 - 12/2019
3	Ischemic Stroke 05/2024 - 11/2007
3	Insulin Resistance 04/2024 - 03/2009
3	Atrial Fibrillation 11/2023 - 01/2007
3	Prediabetic State (Prediabetes) 01/2023 - 11/2018
3	Overweight 10/2021 - 05/2009
3	Inflammation (Inflammations) 09/2017 - 07/2009
3	Acute Coronary Syndrome 01/2015 - 04/2014
2	Heart Failure 05/2024 - 06/2009
2	Chronic Renal Insufficiency 05/2024 - 01/2015
2	Dementia (Dementias) 05/2024 - 01/2023
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 02/2016
2	Neoplasms (Cancer) 01/2023 - 11/2022
2	Proteinuria 01/2023 - 03/2014
2	Body Weight (Weight, Body) 10/2020 - 04/2004
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2015
2	Hyperlipidemias (Hyperlipidemia) 02/2016 - 07/2004
2	Unstable Angina 01/2015 - 01/2015
2	Prehypertension 01/2015 - 07/2005
2	Dyslipidemias (Dyslipidemia) 11/2011 - 05/2009
2	Hypotension (Low Blood Pressure) 08/2011 - 04/2007
2	Renal Insufficiency (Renal Failure) 11/2007 - 06/2007
1	Peripheral Arterial Disease 05/2024
1	Congenital Heart Defects (Congenital Heart Defect) 01/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Neointima 11/2022
1	Atherosclerotic Plaque (Atheroma) 02/2022
1	Heart Diseases (Heart Disease) 12/2021

Drug/Important Bio-Agent (IBA)

19	Particulate MatterIBA 04/2024 - 01/2016
15	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 07/2005
13	LipidsIBA 05/2024 - 06/2004
11	SaltsIBA 05/2024 - 03/2009
10	Triglycerides (Triacylglycerol)IBA 04/2024 - 04/2004
9	HDL CholesterolIBA 12/2019 - 11/2005
9	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2015 - 09/2008
8	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 12/2002
8	CholesterolIBA 02/2022 - 07/2004
7	ORALIT (ORS)IBA 01/2021 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 12/2022 - 12/2014
5	LDL CholesterolIBA 01/2023 - 10/2015
5	SodiumIBA 01/2022 - 03/2009
4	CreatinineIBA 01/2023 - 04/2007
4	Dietary SodiumIBA 12/2017 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2006
3	Long Noncoding RNAIBA 11/2022 - 01/2018
3	TeaIBA 12/2020 - 04/2014
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2004 - 06/2003
2	Blood Glucose (Blood Sugar)IBA 02/2023 - 11/2005
2	oxidized low density lipoproteinIBA 01/2023 - 12/2019
2	Apolipoproteins E (ApoE)IBA 11/2022 - 02/2016
2	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2015
2	CytokinesIBA 02/2022 - 04/2009
2	Isoleucine (L-Isoleucine)FDA Link 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 05/2018 - 01/2015
2	PotassiumIBA 12/2017 - 10/2012
2	SootIBA 01/2016 - 04/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2015 - 06/2009
2	Insulin (Novolin)FDA Link 01/2015 - 04/2004
2	Epithelial Sodium ChannelsIBA 11/2014 - 08/2011
2	EnzymesIBA 03/2014 - 09/2008
2	AdiponectinIBA 06/2013 - 05/2012
2	C-Reactive ProteinIBA 07/2009 - 01/2005
2	HDL LipoproteinsIBA 11/2007 - 04/2007
2	Adrenergic Receptors (Adrenergic Receptor)IBA 06/2006 - 02/2003
1	VaccinesIBA 01/2023
1	cyclo(Arg-Pro) (CI 4)IBA 11/2022
1	ApolipoproteinsIBA 11/2022
1	A 17 (A-17)IBA 11/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	gamma-glutamylphenylalanineIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	hexanoylcarnitineIBA 01/2022
1	3-methoxytyramine (methoxytyramine)IBA 01/2022
1	Histidine (L-Histidine)FDA Link 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Valine (L-Valine)FDA Link 01/2022
1	threonic acid (threonate)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2022
1	gamma-glutamyl-leucineIBA 01/2022
1	ribothymidine (5-methyluridine)IBA 01/2022
1	Sulfates (Sulfates, Inorganic)IBA 01/2022

Therapy/Procedure

4	Therapeutics 05/2024 - 10/2004
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2007 - 06/2007